Abstract
A patient with anaplastic meningioma and lung metastases resistant to conventional treatment underwent radiopeptide therapy with 177Lu- DOTA-octreotate in our institute. The treatment resulted in significant improvement in patient's quality of life and inhibition of tumor progression. This case may eventually help to establish the value of radiopeptide therapy in patients with this rare condition. © 2011 Sabet et al; licensee BioMed Central Ltd.
Author supplied keywords
Cite
CITATION STYLE
Sabet, A., Ahmadzadehfar, H., Herrlinger, U., Wilinek, W., Biersack, H. J., & Ezziddin, S. (2011). Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report. Radiation Oncology, 6(1). https://doi.org/10.1186/1748-717X-6-94
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.